AU2007277146B2 - Compositions and methods for diagnosing patients with acute atherosclerotic syndromes - Google Patents

Compositions and methods for diagnosing patients with acute atherosclerotic syndromes Download PDF

Info

Publication number
AU2007277146B2
AU2007277146B2 AU2007277146A AU2007277146A AU2007277146B2 AU 2007277146 B2 AU2007277146 B2 AU 2007277146B2 AU 2007277146 A AU2007277146 A AU 2007277146A AU 2007277146 A AU2007277146 A AU 2007277146A AU 2007277146 B2 AU2007277146 B2 AU 2007277146B2
Authority
AU
Australia
Prior art keywords
gpi
domain
iga
antibodies
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU2007277146A
Other languages
English (en)
Other versions
AU2007277146A1 (en
Inventor
Walter L. Binder
G. Michael Iverson
Gary L. Norman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Werfen North America
Original Assignee
Inova Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inova Diagnostics Inc filed Critical Inova Diagnostics Inc
Publication of AU2007277146A1 publication Critical patent/AU2007277146A1/en
Application granted granted Critical
Publication of AU2007277146B2 publication Critical patent/AU2007277146B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/323—Arteriosclerosis, Stenosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Rehabilitation Therapy (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2007277146A 2006-07-26 2007-07-26 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes Expired - Fee Related AU2007277146B2 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US83375706P 2006-07-26 2006-07-26
US60/833,757 2006-07-26
US91822507P 2007-03-14 2007-03-14
US60/918,225 2007-03-14
PCT/US2007/016853 WO2008013914A2 (en) 2006-07-26 2007-07-26 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes

Publications (2)

Publication Number Publication Date
AU2007277146A1 AU2007277146A1 (en) 2008-01-31
AU2007277146B2 true AU2007277146B2 (en) 2011-10-20

Family

ID=38982086

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2007277146A Expired - Fee Related AU2007277146B2 (en) 2006-07-26 2007-07-26 Compositions and methods for diagnosing patients with acute atherosclerotic syndromes

Country Status (6)

Country Link
US (2) US7745146B2 (enExample)
EP (1) EP2047263A4 (enExample)
JP (1) JP2009544971A (enExample)
AU (1) AU2007277146B2 (enExample)
CA (1) CA2658824A1 (enExample)
WO (1) WO2008013914A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7745146B2 (en) * 2006-07-26 2010-06-29 Inova Diagnostics, Inc. Compositions and methods for diagnosing patients with acute atherosclerotic syndrome
JP2010515023A (ja) * 2006-12-22 2010-05-06 アボット・ラボラトリーズ 心血管系自己免疫疾患パネルおよびその使用方法
CN102272598B (zh) * 2009-01-02 2014-06-18 福升兴业股份有限公司 用以诊断自体免疫疾病之人工合成肽及试剂盒
EP2580593A4 (en) * 2010-06-10 2014-04-16 Myra Lipes DIAGNOSIS OF MYOCARDIAL AUTOIMMUNITY IN HEART DISEASES
WO2012067165A1 (ja) * 2010-11-17 2012-05-24 国立大学法人愛媛大学 自己免疫疾患に関与するタンパク質の解析方法及び該疾患の検査方法
CN102156190A (zh) * 2010-12-31 2011-08-17 深圳市亚辉龙生物科技有限公司 一种测定抗β2糖蛋白I抗体IgG/A/M的方法及试剂装置
JP6399987B2 (ja) * 2015-09-11 2018-10-03 ヤマサ醤油株式会社 抗β２−ＧＰＩ抗体の測定法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0250119A3 (en) * 1986-06-20 1990-04-18 Vasocor Atherosclerotic anti-idiotype antibody immunoassay and reagents
IL84160A0 (en) * 1986-10-16 1988-03-31 Vasocor Method and kit for immune complex assay
US4981785A (en) 1988-06-06 1991-01-01 Ventrex Laboratories, Inc. Apparatus and method for performing immunoassays
US5376313A (en) 1992-03-27 1994-12-27 Abbott Laboratories Injection molding a plastic assay cuvette having low birefringence
US5998223A (en) * 1993-11-16 1999-12-07 Yamasa Corporation Method of assaying autoimmune anticardiolipin antibody and kit therefor
JP2000502450A (ja) 1995-12-22 2000-02-29 アボツト・ラボラトリーズ 蛍光偏光免疫アッセイによる診断法
US5885529A (en) 1996-06-28 1999-03-23 Dpc Cirrus, Inc. Automated immunoassay analyzer
US6585210B1 (en) 2002-06-19 2003-07-01 Super Link Electronics Co., Ltd. Secure pen holding mechanism
CA2776927C (en) * 2004-04-15 2014-08-12 Athera Biotechnologies Ab Phosphorylcholine conjugates and corresponding antibodies
US7745146B2 (en) * 2006-07-26 2010-06-29 Inova Diagnostics, Inc. Compositions and methods for diagnosing patients with acute atherosclerotic syndrome

Also Published As

Publication number Publication date
US8338117B2 (en) 2012-12-25
JP2009544971A (ja) 2009-12-17
US7745146B2 (en) 2010-06-29
CA2658824A1 (en) 2008-01-31
WO2008013914A9 (en) 2008-10-23
WO2008013914A2 (en) 2008-01-31
US20080153115A1 (en) 2008-06-26
EP2047263A2 (en) 2009-04-15
AU2007277146A1 (en) 2008-01-31
WO2008013914A3 (en) 2008-12-31
EP2047263A4 (en) 2009-11-18
US20100311089A1 (en) 2010-12-09

Similar Documents

Publication Publication Date Title
AU2007320051B2 (en) Methods and assays for detecting GP73-specific autoantibodies
US8338117B2 (en) Compositions and methods for diagnosing patients with acute atherosclerotic syndrome
Goëb et al. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome
WO2011026036A1 (en) Detecting circulating cartilage oligomeric matrix protein in liver cirrhosis
US7754436B2 (en) Diagnostic assay for stroke
US7258994B2 (en) Saliva immunoassay for detection of antibodies for cardiovascular disease
SG194883A1 (en) Method for the diagnosis of early rheumatoid arthritis
US20090176251A1 (en) Methods for Diagnosing Celiac Disease Based on the Level of Anti-Gliadin and Anti-tTG IgA and IgG Antibodies
EP2380027B1 (en) Diagnostic prediction of rheumatoid arthritis and systemic lupus erythematosus
AU771535B2 (en) Method of diagnosing Sjogren's syndrome
JPWO2002042769A1 (ja) 抗ラミニン−１抗体の測定法およびその応用
TWI420106B (zh) Soluble CD14 as a biomarker for detection of coronary artery disease
JP4217717B2 (ja) 血清由来ヒアルロナン結合性タンパク質−ヒアルロン酸結合体の測定法および測定キット
WO2024077068A1 (en) Anti-vimentin antibodies are associated with higher severity of sjögren's syndrome
WO2013163105A1 (en) Biomarkers for hepatocellular carcinoma

Legal Events

Date Code Title Description
MK25 Application lapsed reg. 22.2i(2) - failure to pay acceptance fee